Febuxostat
29 NDCs across 14 manufacturers|27 Generic,2 Brand
Febuxostat is used to treat gout, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 13, 2009, and the first generic was approved Jul 1, 2019. FDA's Orange Book lists 26 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $41 million on Febuxostat across 341,000 claims for 84,000 beneficiaries.
Febuxostat is available as 29 NDCs from 14 manufacturers (27 generic, 2 brand), with NADAC prices from $0.19 to $10.54 per EA — the most expensive product costs about 55× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
29
27G / 2B
Manufacturers
14
competing in market
Price Spread
$0.19 – $10.54
per EA
7d Activity
avg -7.7% WoW · of 29 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Major Pharmaceuticals manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Xanthine Oxidase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
14 manufacturers producing FEBUXOSTAT(4 pricing outliers)
Frequently Asked Questions
What is Febuxostat used to treat?
Febuxostat is used to treat gout, per the National Library of Medicine's MED-RT classification.
When did Febuxostat become available as a generic?
FDA approved the first generic Febuxostat (ANDA) on Jul 1, 2019. The Orange Book currently lists 26 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Febuxostat?
In 2024, Medicare Part D spent $41 million on Febuxostat across 341,000 claims for 84,000 beneficiaries.
How many Febuxostat products are on the market?
The Febuxostat drug market contains 29 NDCs from 14 manufacturers — 27 generic and 2 brand products.
What is the price range for Febuxostat?
NADAC reference prices for Febuxostat range from $0.1911 to $10.5440 per EA — the most expensive product costs about 55× the cheapest.
Is generic Febuxostat cheaper than brand?
The average generic NADAC for Febuxostat is $0.2533 per EA, versus $10.5408 for brand-labeled products — brand versions average about 42× the generic price.
Which manufacturers make Febuxostat?
14 manufacturers list Febuxostat in NADAC. Ranked by number of NDCs, the largest are Major Pharmaceuticals (4), Takeda Pharmaceuticals America, Inc. (2), Dr. Reddy's Laboratories Inc. (2), Viona Pharmaceuticals Inc. (2), Hikma Pharmaceuticals USA Inc. (2).
How has the price of Febuxostat changed recently?
Over the past 7 days, 2 Febuxostat NDCs rose and 23 fell, with a market-wide average change of -7.7%.